(Q51547717)

6 April 2018

title

Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. (English)

1 reference

6 April 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

1

Anker SD

1 reference

6 April 2018

author name string

Volterrani M

2

1 reference

6 April 2018

Pflaum CD

3

1 reference

6 April 2018

Strasburger CJ

4

1 reference

6 April 2018

Osterziel KJ

5

1 reference

6 April 2018

Doehner W

6

1 reference

6 April 2018

Ranke MB

7

1 reference

6 April 2018

Poole-Wilson PA

8

1 reference

6 April 2018

Giustina A

9

1 reference

6 April 2018

Dietz R

10

1 reference

6 April 2018

Coats AJ

11

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 August 2001

1 reference

6 April 2018

Journal of the American College of Cardiology

published in

1 reference

6 April 2018

volume

38

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

443-452

1 reference

6 April 2018

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Acquired growth hormone resistance in patients with hypercatabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Acquired growth hormone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Growth hormone in the treatment of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

A placebo-controlled study of growth hormone in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Haemodynamic effects of intravenous growth hormone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Cardiovascular effects of GH

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Growth hormone, cardiomyocyte contractile reserve, and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Potential for growth factor treatment of muscle disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Increased mortality associated with growth hormone treatment in critically ill adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Growth hormone therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Recombinant human growth hormone for AIDS-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Safety of high doses of recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Cardiac failure responding to growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Treatment of end-stage cardiac failure with growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver disease. EMALD group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

Growth hormone therapy for protein catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901385-7

7 January 2021

10.1016/S0735-1097(01)01385-7

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018